Kanishka Pothula
Direktor/Vorstandsmitglied bei TANGO THERAPEUTICS, INC.
Profil
Kanishka Pothula is currently the Director at Exo Therapeutics, Inc. and Tango Therapeutics, Inc. He is also the Managing Partner at Nextech Invest AG.
Previously, he worked as the Managing Director at BVF Partners LP from 2012 to 2023.
He also served as a Director at Relay Therapeutics, Inc. and an Associate at BroadOak Capital Partners LLC from 2010 to 2011.
Mr. Pothula holds a graduate degree from Georgetown University, which he received in 2008, and an undergraduate degree from the University of California, which he received in 2006.
Aktive Positionen von Kanishka Pothula
| Unternehmen | Position | Beginn |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2023 |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 05.10.2021 |
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Kanishka Pothula
| Unternehmen | Position | Ende |
|---|---|---|
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Portfolio Manager-Aktien | 01.01.2023 |
BroadOak Capital Partners LLC
 BroadOak Capital Partners LLC Investment ManagersFinance BroadOak Capital Partners LLC (BroadOak Capital Partners) is a private equity firm founded in 2006 by Bill Snider and Lars Hanan. The firm is headquartered in Maryland. | Corporate Officer/Principal | 31.12.2011 |
| RELAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kanishka Pothula
| University of California | Undergraduate Degree |
| Georgetown University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RELAY THERAPEUTICS, INC. | Health Technology |
| TANGO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
BroadOak Capital Partners LLC
BroadOak Capital Partners LLC Investment ManagersFinance BroadOak Capital Partners LLC (BroadOak Capital Partners) is a private equity firm founded in 2006 by Bill Snider and Lars Hanan. The firm is headquartered in Maryland. | Finance |
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Finance |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Finance |
